Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Alexandre B Cavalcanti, View ORCID ProfileFernando G Zampieri, Luciano CP Azevedo, Regis Rosa, Álvaro Avezum, Viviane C Veiga, Renato D. Lopes, Letícia Kawano-Dourado, Lucas P Damiani, Adriano J Pereira, Ary Serpa-Neto, Remo Furtado, Bruno Tomazini, Fernando A Bozza, Israel S. Maia, Maicon Falavigna, Thiago C Lisboa, Henrique Fonseca, Flávia R Machado, Otavio Berwanger, for the COALITION COVID-19 Brasil I Investigators
doi: https://doi.org/10.1101/2020.05.19.20106997
Alexandre B Cavalcanti
1HCor Research Institute, São Paulo, Brazil
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Fernando G Zampieri
1HCor Research Institute, São Paulo, Brazil
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Luciano CP Azevedo
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
3Hospital Sírio Libanês Research and Education Institute, São Paulo, Brazil
Regis Rosa
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
4Hospital Moinhos de Vento, Porto Alegre, Brazil
Álvaro Avezum
5Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Viviane C Veiga
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
6BP – A Beneficência Portuguesa de São Paulo, São Paulo, Brazil
Renato D. Lopes
7Brazilian Clinical Research Institute (BCRI), São Paulo, Brazil.
8Duke University Medical Center – Duke Clinical Research Institute – Durham, North Carolina, USA.
Letícia Kawano-Dourado
1HCor Research Institute, São Paulo, Brazil
Lucas P Damiani
1HCor Research Institute, São Paulo, Brazil
Adriano J Pereira
9Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil
Ary Serpa-Neto
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
10Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil
Remo Furtado
9Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil
11Heart Institute, University of São Paulo, São Paulo, Brazil
Bruno Tomazini
3Hospital Sírio Libanês Research and Education Institute, São Paulo, Brazil
Fernando A Bozza
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Israel S. Maia
1HCor Research Institute, São Paulo, Brazil
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Maicon Falavigna
4Hospital Moinhos de Vento, Porto Alegre, Brazil
Thiago C Lisboa
1HCor Research Institute, São Paulo, Brazil
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Henrique Fonseca
9Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil
Flávia R Machado
2Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Otavio Berwanger
8Duke University Medical Center – Duke Clinical Research Institute – Durham, North Carolina, USA.
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 26, 2020.
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Alexandre B Cavalcanti, Fernando G Zampieri, Luciano CP Azevedo, Regis Rosa, Álvaro Avezum, Viviane C Veiga, Renato D. Lopes, Letícia Kawano-Dourado, Lucas P Damiani, Adriano J Pereira, Ary Serpa-Neto, Remo Furtado, Bruno Tomazini, Fernando A Bozza, Israel S. Maia, Maicon Falavigna, Thiago C Lisboa, Henrique Fonseca, Flávia R Machado, Otavio Berwanger, for the COALITION COVID-19 Brasil I Investigators
medRxiv 2020.05.19.20106997; doi: https://doi.org/10.1101/2020.05.19.20106997
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Alexandre B Cavalcanti, Fernando G Zampieri, Luciano CP Azevedo, Regis Rosa, Álvaro Avezum, Viviane C Veiga, Renato D. Lopes, Letícia Kawano-Dourado, Lucas P Damiani, Adriano J Pereira, Ary Serpa-Neto, Remo Furtado, Bruno Tomazini, Fernando A Bozza, Israel S. Maia, Maicon Falavigna, Thiago C Lisboa, Henrique Fonseca, Flávia R Machado, Otavio Berwanger, for the COALITION COVID-19 Brasil I Investigators
medRxiv 2020.05.19.20106997; doi: https://doi.org/10.1101/2020.05.19.20106997
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (667)
- Anesthesia (181)
- Cardiovascular Medicine (2644)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12219)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4093)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2654)
- Health Policy (1005)
- Hematology (362)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (434)
- Neurology (3874)
- Nursing (209)
- Nutrition (577)
- Oncology (2026)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6521)
- Radiology and Imaging (1400)
- Respiratory Medicine (871)
- Rheumatology (407)
- Sports Medicine (342)
- Surgery (447)
- Toxicology (53)
- Transplantation (185)
- Urology (165)